Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 54Lymphoma 40Lymphoma, Large B-Cell, Diffuse 28Lymphoma, Non-Hodgkin 21Hodgkin Disease 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Osteosarcoma 17Testicular Neoplasms 15Burkitt Lymphoma 15Leukemia 14Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Follicular 13Ovarian Neoplasms 12Lymphoma, Mantle-Cell 12Neuroectodermal Tumors, Primitive, Peripheral 11Testicular Germ Cell Tumor 10Liposarcoma 10Histiocytoma, Malignant Fibrous 10Hemangiosarcoma 10Fibrosarcoma 10Sarcoma, Synovial 9Rhabdomyosarcoma 9Neurofibrosarcoma 9Lymphoma, Large-Cell, Anaplastic 9Leiomyosarcoma 9Teratoma 8Recurrence 8Neuroblastoma 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8

Interventions

Dexamethasone 33Palonosetron 27Aprepitant 24Ondansetron 23Granisetron 14Calcium Dobesilate 8Therapeutics 7Olanzapine 6fosaprepitant 5dexamethasone acetate 5netupitant, palosentron drug combination 4casopitant 4Doxorubicin 4Cyclophosphamide 4Acupressure 4netupitant 3dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Radiotherapy 3Metoclopramide 3Dronabinol 3Analgesia 3ramosetron 2ginger extract 2dexamethasone 21-phosphate 2Vincristine 2Tablets 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Vomiting × Ifosfamide × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡